A bioadaptor implant that actively adapts to vessel physiology was linked to lower target lesion failure and target vessel ...

After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...

Celebrating a groundbreaking milestone in heart health innovationWashington, D.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- This ...

"TCT 2025: Elixir Medical’s arterial implant drops coronary events by nearly 50%" was originally created and published by ...

In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

CHICAGO.-- Northwestern's Bluhm Cardiovascular Institute recently enrolled its first subject in ABSORB III, a clinical trial to study a "disappearing" heart device for the treatment of coronary artery ...

Nov. 2 (UPI) --For patients with stable angina, coronary artery stents may have more of a placebo effect than previously thought, researchers in England report in a new study. Researchers from the ...

Analysis suggests stents aren't as beneficial as previously thought. Feb. 28, 2012— -- Inserting stents to open a blocked artery is a common way to treat coronary artery disease. But increasing ...

New study findings show that utilizing super-high-pressure non-compliant balloons (NCB) is non-inferior to intravascular ...

The placement of a stent to repair a narrowed artery in the heart has become routine worldwide. A new analysis of earlier clinical trials shows that inserting a stent has no benefit over standard ...